SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Concerns about Chinese memory maker CXMTs progress on a denser DRAM design are weighing on Micron and other memory stocks, alongside broader semiconductor weakness. Traders debate whether the technology poses a meaningful future threat or is years from competing at scale, while bullish voices point to Microns AI-memory demand and fundamentals.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisk is being swept up in a semiconductor and memory-stock selloff as traders react to Chinas CXMT memory-design progress and concerns about the funding and returns on AI infrastructure spending. The community is divided between seeing an overreactionsome note CXMTs announcement concerns DRAM while SanDisk primarily sells NANDand fearing stronger competition, oversupply, and a slowdown in AI demand.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

Weakness in semiconductor and memory stocks, amid concerns about Chinese chip competition, is weighing on QQQ. Traders are split between viewing the tech-led pullback as the start of a deeper correction and seeing it as a buyable dip, with inflation data and bank earnings adding uncertainty.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is drawing attention amid a sharp semiconductor-sector pullback, with traders linking the weakness to concerns about AI spending and demand, alongside heavy selling in memory-chip stocks. The community is divided between buyers calling the drop an overreaction and bearish traders warning that momentum remains weak and the leveraged ETF can amplify losses.

AST SpaceMobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an intellectual property and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

Deutsche Banks Buy upgrade is supporting a rebound after the selloff sparked by SpaceXs spectrum deal, while BlueBirds 1416 reaching Florida adds progress on satellite deployment. Bulls argue SpaceXs push into mobile could strengthen ASTSs role with established carriers; bears remain focused on launch delays, execution and competition.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Reports that OpenAIs latest AI workload is running on Nvidia GPUs rather than Cerebras hardware have fueled concern about Cerebras reliance on OpenAI and pressured the shares. Traders also cite upcoming share unlocks as a potential source of selling, while bulls view the decline as a buying opportunity and bears warn of further downside.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius is caught in a broader selloff in AI and neocloud stocks, with traders focused on a report that OpenAIs annualized revenue was below previously circulated estimates and growing concerns about AI infrastructure spending, debt, and valuations. Some see the reaction as an overblown response to differing revenue-accounting methods and remain bullish on Nebiuss customer demand, while others fear the sectors momentum is fading.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel shares are caught in a broader semiconductor selloff as traders weigh concerns about the cost and returns of AI infrastructure spending, alongside worries about AI revenue expectations. The steep decline has prompted frustration and bearish talk about a breakdown, while other traders view the pullback as oversold and are watching the $100 area for support.

SK hynix, Inc. engages in the design, manufacture, and sale of semiconductor products. Its products include dynamic random access memory, not-AND flash memory, and multi-chip package. The company was founded on October 15, 1949 and is headquartered in Icheon, South Korea.

SK Hynix Inc - ADR

SK Hynix is under pressure amid concern that Chinas CXMT is advancing denser DRAM technology and could become a future competitor in server memory. Traders disagree on the significance: some fear added supply and competition, while others argue CXMTs claims remain unproven and commercial impact is distant; weakness in Korean markets is also weighing on sentiment.

Direxion Shares ETF Trust - Direxion Daily MSCI South Korea Bull 3X ETF

Direxion Daily South Korea Bull 3X Shares

A sharp selloff in South Koreas KOSPI is driving attention to KORU, with traders noting that the funds 3 leverage magnifies the indexs decline. Some attribute pressure on Korean chip stocks to concerns about Chinese memory competition, while others are buying the dip or looking to short further weakness.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Cathie Wood-Led Ark Invest Sells AMD, SPCX, GOOG Stocks — But Loads Up On CMPS, NTLA, CRSP And Other Healthcare Firms

Equity

The trades put some of Ark's better-known holdings on the sell side, including AMD, Alphabet, and SpaceX, while its genomics-focused ARK Genomic Revolution ETF continued to add to biotech companies.

Guardant Health Announces Approval in Europe of Guardant360 CDx as Companion Diagnostic for AstraZenecas ETCAMAH (camizestrant) in Advanced ER-positive Breast Cancer

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that Guardant360 CDx has received CE-marking under Europes in Vitro Diagnostic Medical Devices Regulation as a companion diagnostic (CDx) to identify patients with estrogen receptor (ER)-positive...

Guardant Health to Report Third Quarter 2026 Financial Results on November 5, 2026

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will report financial results for the third quarter 2026 after market close on Thursday, November 5, 2026. Company management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time...

Guardant Health COSMOS Study Published in Cancer Research Communications Validates Utility of Guardant Reveal Liquid Biopsy Test for Predicting Recurrence in Melanoma

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced Cancer Research Communications, a journal of the American Association for Cancer Research, has published results from the COSMOS-MEL01 study (UMIN000042040). The study is the first published prospective...

Cathie Wood's ARK Invest Buys AVAV Stock Again, Trims GOOGL Stake And Sells Iridium

Cathie Wood's ARK Invest bought another 9,037 AeroVironment shares Tuesday, extending its AVAV buying to a second consecutive session.


Guardant Healths Shield Blood Test Covered by EviCore by Evernorth for Colorectal Cancer Screening

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shield blood test for colorectal cancer screening (CRC) will be covered in EviCore by Evernorth clinical guidelines effective January 1, 2027, per ACS guidelines. EviCore is a Cigna-owned company and the...

Guardant Health and Collaborators to Present 20 Abstracts Highlighting Portfolio of Liquid Biopsy Tests for Early Detection and Ongoing Treatment Management at 2026 World Conference on Lung Cancer

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that the company and its research collaborators will present 20 abstractsincluding one mini oral presentationshowcasing advances in methylation-based tumor classification and liquid biopsy technology across...

Business Insider Names Guardant Health One of America's Most Innovative Businesses

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it has been named to Business Insiders America's Most Innovative Businesses 2027 list, earning the highest rating available with a five-star recognition awarded to only other 12 biotechnology research...

Guardant Health Announces Landmark FDA Approval of Guardant360 CDx as Companion Diagnostic for AstraZenecas ETCAMAH (camizestrant) in Advanced Breast Cancer

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that the U.S. Food and Drug Administration (FDA) has approved Guardant360 CDx as a companion diagnostic (CDx) to identify patients with hormone receptor (HR)-positive, HER2-negative advanced or metastatic...

Guardant Healths Shield Blood Test Covered by Carelon Health Services for Colorectal Cancer Screening

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shield blood test for colorectal cancer screening (CRC) will be covered in Carelon Healthcare Services clinical guidelines effective November 15. Carelon Healthcare Services is one of the largest specialty...

Guardant Health, Inc. is a precision oncology company, which engages in the provision of treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in December 2011 and is headquartered in Palo Alto, CA.

Current Price	$162.79
Prev Close	$167.47
Open	$168.26
Dividend Yield	0.00%
50-Day Moving Average	$167.88
Beta	1.30
Avg. Volume	1.83M
PE Ratio	-46.52

52-Week High	$191.05
52-Week Low	$61.00
Market Capitalization	$22.47B
EPS (Annual)	-$3.32
Price to Book	-97.60
Revenue Per Employee	$391,867.92

Feed

News

Sentiment

Earnings

Fundamentals

Info

GH Fundamentals